14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $0.775 0 %
High/ Low $0.775 - $0.775 0%
Chg 7 Days N/A $0.775 $0.775
Chg 30 Days N/A $0.775 $0.775
Chg 12 mos 318.24 % $0.185 $0.775
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 33.06 % Width: 18,036.74 %
Pred. range - 3 mos $0.775 - $0.775 0 % - 0 %
Pred. range - 12 mos $0.0321 - $5.82 -95.86 % - 651.02 %
Short MA avg 3 mos Buy Sep 13, 2023 - 59 days
Long MA avg 3 mos Buy Oct 24, 2023 - 31 days
Short/Long MA avg 3 mos Buy Oct 24, 2023 - 31 days
Short MA avg 12 mos Buy Oct 04, 2023 - 45 days
Long MA avg 12 mos Sell Aug 10, 2023 - 82 days
Short/Long MA avg 12 mos Sell Aug 24, 2023 - 72 days
Pivot Short Buy Dec 05, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the ... ADMP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT